
MOLECULAR CYTOGENETIC CHARACTERIZATION OF
AN inv(Y)(p11.2q11.221~q11.222) IN A SYRIAN FAMILY Al-Achkar W1,*, Wafa A1, Al-Ablog A1, Moassass F1, Liehr T2 *Corresponding Author: Professor Walid Al-Aachkar, Department of Molecular Biology and Biotechnology,
Division of Human Genetics, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria; Tel.: +963-
11-213-2580; Fax: +963-11-611-2289; E-mail: ascientific@aec.org.sy page: 73
|
MATERIALS AND METHODS
Patient History. A 37-year-old male, his unrelated
32-year-old wife and the two sons of the family are
reported, aged 15 and 17, respectively. The mother
was healthy and had a karyotype 46,XX. Father and both sons had varying features of mental retardation
but otherwise normal phenotypes. The parents did
not have any history of miscarriages.
Cytogenetic and Molecular Cytogenetic Analyses.
Cytogenetic analysis using GTG-banding was
performed according to standard procedures [10]. A
minimum of 20 metaphases analyzed from stimulated
peripheral blood cultures were analyzed. Karyotypes
were described according to the International System
for Human Cytogenetic Nomenclature [11].
Fluorescence in situ hybridization (FISH) was
carried out on the metaphases using commercially
available probes (LSI SRY), subtelomeric for Xp/Yp
and Xq/Yq and centromeric for Y (DYZ3) (Abbott
Molecular/Vysis, Des Plaines, IL, USA). Additionally
centromere-near probes of the previously reported
subcentromeric multicolor-FISH (subcenM-FISH)
mix were applied [8]. A minimum of 20 metaphases
spreads were analyzed. The results were evaluated
on a fluorescence microscope (AxioImager.Z1 mot;
Zeiss, Jena, Germany) equipped with appropriate
filter sets to discriminate between a maximum of five
fluorochromes and the counterstain DAPI (4’,6-diamino-
2-phenylindole). Image capturing and processing
were carried out using an Isis imaging system
(MetaSystems, Altlussheim, Germany).
Molecular Analysis. The azoospermia factor
(AZF) microdeletions on the Y-chromosome were
detected according to the procedure of Al-Achkar
et al. [12].
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|